Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

ABX-IL-8 slated to enter clinical testing

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Jan. 5, 1998

Structurally distinct vitamin D analogues from Leo

Jan. 5, 1998

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Apligraf scheduled for FDA advisory panel review

Dec. 24, 1997

Life Medical Sciences terminates Piliel trials early; refocuses R&D efforts

Dec. 22, 1997

Antiacne activity of oral contraceptives

Dec. 19, 1997

AEterna's psoriasis agent moves to phase I/II in Canada

Dec. 18, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...